Cargando…

TWIST2 and the PPAR signaling pathway are important in the progression of nonalcoholic steatohepatitis

BACKGROUND: To investigate the roles of the transcription factors twist family bHLH transcription factor 1 (TWIST1), twist family bHLH transcription factor 2 (TWIST2), and peroxisome proliferator activated receptor gamma (PPARγ) in the progression of nonalcoholic steatohepatitis. METHODS: The protei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yanmei, Ge, Xiaoxiao, Li, Yongqing, Zhang, Bingyang, Wang, Peijun, Hao, Mingju, Gao, Peng, Zhao, Yueyi, Sun, Tao, Lu, Sumei, Ma, Wanshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059034/ https://www.ncbi.nlm.nih.gov/pubmed/33879188 http://dx.doi.org/10.1186/s12944-021-01458-0

Ejemplares similares

The role and possible mechanism of the long noncoding RNA LINC01260 in nonalcoholic fatty liver disease
por: Ge, Xiaoxiao, et al.
Publicado: (2022)

A possible regulatory link between Twist 1 and PPARγ gene regulation in 3T3-L1 adipocytes
por: Ren, Rui, et al.
Publicado: (2016)

Reduced expression of Twist 1 is protective against insulin resistance of adipocytes and involves mitochondrial dysfunction
por: Lu, Sumei, et al.
Publicado: (2018)

Twist 1 regulates the expression of PPARγ during hormone-induced 3T3-L1 preadipocyte differentiation: a possible role in obesity and associated diseases
por: Ma, Wanshan, et al.
Publicado: (2014)

METTL3 exacerbates insulin resistance in hepatocytes by regulating m(6)A modification of cytochrome P450 2B6
por: Li, Yongqing, et al.
Publicado: (2023)

Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis
por: Seen, Tasur Kumar, et al.
Publicado: (2021)

Genistein Attenuates Nonalcoholic Steatohepatitis and Increases Hepatic PPARγ in a Rat Model
por: Susutlertpanya, Warinda, et al.
Publicado: (2015)

PPAR Alpha as a Metabolic Modulator of the Liver: Role in the Pathogenesis of Nonalcoholic Steatohepatitis (NASH)
por: Todisco, Simona, et al.
Publicado: (2022)

Necroptosis in Nonalcoholic Steatohepatitis
por: Gautheron, Jérémie, et al.
Publicado: (2015)

Exosomal microRNAs and Progression of Nonalcoholic Steatohepatitis (NASH)
por: Qi, Xiaoyan, et al.
Publicado: (2022)

Surveillance of the progression and assessment of treatment endpoints for nonalcoholic steatohepatitis
por: Shi, Yi-wen, et al.
Publicado: (2023)

Herpetrione, a New Type of PPARα Ligand as a Therapeutic Strategy Against Nonalcoholic Steatohepatitis
por: Linghu, Lang, et al.
Publicado: (2023)

The methyltransferase METTL3 negatively regulates nonalcoholic steatohepatitis (NASH) progression
por: Li, Xinzhi, et al.
Publicado: (2021)

Increased Glutaminolysis Marks Active Scarring in Nonalcoholic Steatohepatitis Progression
por: Du, Kuo, et al.
Publicado: (2019)

Apoptosis and diagnosis of nonalcoholic steatohepatitis
por: Kim, Chang Wook, et al.
Publicado: (2011)

Antioxidant Therapy in Nonalcoholic Steatohepatitis
por: Al-Busafi, Said A., et al.
Publicado: (2012)

The Immune Landscape in Nonalcoholic Steatohepatitis
por: Narayanan, Sowmya, et al.
Publicado: (2016)

Betel Chewing and Nonalcoholic Steatohepatitis
por: Bleibel, Wissam, et al.
Publicado: (2018)

The metabolic basis of nonalcoholic steatohepatitis
por: Chakravarthy, Manu V., et al.
Publicado: (2020)

Pathogenesis of Nonalcoholic Steatohepatitis: An Overview
por: Parthasarathy, Gopanandan, et al.
Publicado: (2020)

Insulinoma in Patient With Nonalcoholic Steatohepatitis
por: Cain, Daniel, et al.
Publicado: (2023)

Challenges and opportunities in nonalcoholic steatohepatitis
por: Wang, Xiaobo
Publicado: (2022)

Overexpression of Hepcidin Alleviates Steatohepatitis and Fibrosis in a Diet-induced Nonalcoholic Steatohepatitis
por: Chen, Hui, et al.
Publicado: (2022)

Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis
por: Tsurusaki, Shinya, et al.
Publicado: (2019)

Targeting MRG15 for the treatment of nonalcoholic steatohepatitis
por: Zhang, Yao, et al.
Publicado: (2022)

RING finger protein 13 protects against nonalcoholic steatohepatitis by targeting STING-relayed signaling pathways
por: Lin, Zhibin, et al.
Publicado: (2023)

Caspase-11–Mediated Hepatocytic Pyroptosis Promotes the Progression of Nonalcoholic Steatohepatitis
por: Zhu, Yingwei, et al.
Publicado: (2021)

Effect of tocotrienol on the primary progression of nonalcoholic steatohepatitis in a mouse model
por: Noichi, Jun, et al.
Publicado: (2022)

Shugan Xiaozhi Decoction Attenuates Nonalcoholic Steatohepatitis by Enhancing PPARα and L-FABP Expressions in High-Fat-Fed Rats
por: Xing, Yu-feng, et al.
Publicado: (2016)

Berberine Prevents Disease Progression of Nonalcoholic Steatohepatitis through Modulating Multiple Pathways
por: Wang, Yanyan, et al.
Publicado: (2021)

CD4 derived double negative T cells prevent the development and progression of nonalcoholic steatohepatitis
por: Sun, Guangyong, et al.
Publicado: (2021)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

Genistein Modulated Lipid Metabolism, Hepatic PPARγ, and Adiponectin Expression in Bilateral Ovariectomized Rats with Nonalcoholic Steatohepatitis (NASH)
por: Pummoung, Sudaporn, et al.
Publicado: (2020)

Wilson's disease masquerading as nonalcoholic steatohepatitis
por: Mahmood, Sabina, et al.
Publicado: (2009)

Familial Hypobetalipoproteinemia-Induced Nonalcoholic Steatohepatitis
por: Lam, Mindy C.W., et al.
Publicado: (2012)

The effect of β-caryophyllene on nonalcoholic steatohepatitis
por: Arizuka, Naoya, et al.
Publicado: (2017)

New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis
por: Mendez-Sanchez, Nahum, et al.
Publicado: (2018)

Repurposing drugs to target nonalcoholic steatohepatitis
por: Sookoian, Silvia, et al.
Publicado: (2019)

The regulatory state of nonalcoholic steatohepatitis and metabolism
por: Omokaro, Stephanie O., et al.
Publicado: (2020)

Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis
por: Sumida, Yoshio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6m9fonn0pmmhtigo681hb9m9af